Home › Medicines › Floxipar
বাংলায় দেখুন
💊

Floxipar

Tablet

🧬 Sparfloxacin 🏢 ACME Laboratories Ltd.
Generic Name Sparfloxacin
Manufacturer ACME Laboratories Ltd.
Unit Price Unit Price: ৳ 15.61 (1 x 10: ৳ 156.10) Strip Price: ৳ 156.10

🔹 Indications

Floxipar is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Floxipar is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Pharmacology

Floxipar is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Floxipar is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Dosage & Administration

Floxipar is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Floxipar is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Interaction

Floxipar is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Floxipar is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Contraindications

Floxipar is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Floxipar is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Side Effects

Floxipar is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Floxipar is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Pregnancy & Lactation

Floxipar is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Floxipar is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Precautions & Warnings

Floxipar is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Floxipar is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔍 People also search for

Floxipar Floxipar Tablet used for Floxipar side effects Floxipar price Floxipar dose Floxipar Tablet uses Is Floxipar safe Floxipar dosage Floxipar alternative Floxipar Bangladesh Sparfloxacin Sparfloxacin price Bangladesh Tablet price Bangladesh ACME Laboratories Ltd. medicine bd

💡 Frequently Asked Questions

Floxipar is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influen...
Floxipar is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influen...
Floxipar is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influen...

User Reviews

⭐
No reviews yet!
Be the first to share your experience.

Write a Review

Alternative Medicines
(Same Generic)

Aciflox Tablet

ACI Limited

Unit Price: ৳ 12.00 (1 x 10: ৳ 120.00) Strip Price: ৳ 120.00

Mega Flox Tablet

Hudson Pharmaceuticals Ltd.

Unit Price: ৳ 15.00 (20's pack: ৳ 300.00)

Piocin Tablet

Millat Pharmaceuticals Ltd.

Unit Price: ৳ 18.00 (6's pack: ৳ 108.00)

Saga Tablet

Square Pharmaceuticals PLC

Unit Price: ৳ 15.05 (3 x 5: ৳ 225.75) Strip Price: ৳ 75.25

Salocin Tablet

Kemiko Pharmaceuticals Ltd.

Unit Price: ৳ 17.05 (10's pack: ৳ 170.50)

Spacin Tablet

SANDOZ (A Novartis Division)

Unit Price: ৳ 26.00 (1 x 10: ৳ 260.00) Strip Price: ৳ 260.00

Spalox Tablet

Edruc Limited

Unit Price: ৳ 16.00 (10's pack: ৳ 160.00)

Spar Tablet

Globe Pharmaceuticals Ltd.

Unit Price: ৳ 20.00 (1 x 10: ৳ 200.00) Strip Price: ৳ 200.00

Salocin Tablet

Kemiko Pharmaceuticals Ltd.

Unit Price: ৳ 17.05 (10's pack: ৳ 170.50)

Spardon Tablet

Apollo Pharmaceutical Ltd.

Unit Price: ৳ 16.00 (12's pack: ৳ 192.00)